Fibromyalgia and bipolar disorder: A potential problem?

Bipolar Disorders

Volumn 12, Issue 5, 2010, Pages 514-520

  Wilke, William S ^a   Gota, Carmen E ^a   Muzina, David J ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Lutheran Hospital Cleveland   (United States)

Author keywords

Beck Depression Inventory (BDI); Bipolar disorder; Depression; Fibromyalgia; Mood Disorder Questionnaire (MDQ)

Indexed keywords

AMFEBUTAMONE; BENZODIAZEPINE; BUSPIRONE; DULOXETINE; GABAPENTIN; MILNACIPRAN; NARCOTIC ANALGESIC AGENT; PREGABALIN; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CLINICAL FEATURE; CLINICAL PRACTICE; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EPWORTH SLEEPINESS SCALE; FEMALE; FIBROMYALGIA; FIBROMYALGIA IMPACT QUESTIONNAIRE DISABILITY INDEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOOD DISORDER QUESTIONNAIRE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOLOGY; SCREENING; TERTIARY HEALTH CARE;

ACTIVITIES OF DAILY LIVING; BIPOLAR DISORDER; FATIGUE; FEMALE; FIBROMYALGIA; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS;

EID: 77955671311     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2010.00848.x     Document Type: Article

References (45)

1. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: sex, pain threshold and fibromyalgia symptoms. J Rheumatol 1995, 22:151-156.
2. Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 2006, 67:1219-1225.
3. Kessler RC, McGonagle KA, Shanyang Z. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Arch Gen Psychiatry 1994, 51:8-19.
4. Güven AZ, Kul Panza E, Gündüz OH. Depression and psychosocial factors in Turkish women with fibromyalgia syndrome. Eura Medicophys 2005, 41:309-313.
5. Post RM, Denicoff KD, Leverich GS. Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 2003, 64:680-690.
6. Carta MG, Cardia C, Mannu F. The high frequency of manic symptoms in fibromyalgia does influence the choice of treatment? Clin Pract Epidemol Ment Health 2006, 2:1-5.
7. Wallace DJ, Gotto J. Hypothesis: bipolar illness with complaints of chronic musculoskeletal pain is a form of pseudofibromyalgia. Semin Arthritis Rheum 2008, 37:256-259.
8. Russell IJ, Mease PJ, Smith TR. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with and without major depression: Results from a 6-months, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain 2008, 136:432-444.
9. Arnold LM, Hess EV, Hudson JI, Welge JA, Berno SE, Keck PE. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med 2002, 112:191-197.
10. Mease PJ, Clauw DJ, Gendreau RM. The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 2009, 36:398-409.
11. Hauser W, Bernardy K, Uceyler N, Sommer C. Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 2009, 301:198-209.
12. Goldberg JF, Perlis RH, Ghaemi SN. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry 2007, 164:1348-1355.
13. Post RM, Altshuler LL, Leverich GS. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertaline. Br J Psychiatry 2006, 189:124-131.
14. Baumer FM, Howe M, Gallelli K, Simeonova DI, Hallmayer J, Chang KD. A pilot study of antidepressant-induced mania in pediatric bipolar disorder: characteristics, risk factors, and the serotonin transporter gene. Biol Psychiatry 2006, 60:1005-1012.
15. Antidepressant use in children, adolescents, and adults http://www.fda.gov/Drugs/DrugSafety/InformationbyDrugClass/ucm096273.htm , FDA.gov, Accessed July 11, 2010
16. Hirschfeld RMA, Williams JBW, Spitzer RL. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry 2000, 157:1873-1875.
17. Wilke WS. New developments in the diagnosis of fibromyalgia syndrome: say goodbye to tender points. Clev Clin J Med 2009, 76:345-352.
18. Beck A, Ward C, Mendelson M, Mock J, Erbauch J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
19. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991, 14:540-545.
20. Bennett RM. The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005, 23(Suppl. 39):S154-S162.
21. Kim B, Wang HR, Son JI, Kim CY, Joo YH. Bipolarity in depressive patients without histories of diagnosis of bipolar disorder and the use of the Mood Disorder Questionnaire for detecting bipolarity. Compr Psychiatry 2008, 49:469-475.
22. Hirschfeld RMA. The Mood Disorder Questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim Care Companion J Clin Psychiatry 2002, 4:9-11.
23. Twiss J, Jones S, Anderson I. Validation of the Mood Disorder Questionnaire for screening for bipolar disorder in a UK sample. J Affect Disord 2008, 110:180-184.
24. Miller CJ, Klugman J, Berv DA, Rosenquist KJ, Ghaemi SN. Sensitivity and specificity of the Mood Disorder Questionnaire for detecting bipolar disorder. J Affect Disord 2004, 81:167-171.
25. Stang P, Frank C, Ulcickas Yood M, Wells K, Burch S. Impact of bipolar disorder: results from a screening study. Prim Care Companion J Clin Psychiatry 2007, 9:42-47.
26. Sanchez-Moreno J, Villagran JM, Gutierrez JR. Adaptation and validation of the Spanish version of the Mood Disorder Questionnaire for the detection of bipolar disorder. Bipolar Disord 2008, 10:400-412.
27. Berger A, Dukes E, Martin S, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with fibromyalgia syndrome. Int J Clin Pract 2007, 61:1498-1508.
28. Jensen B, Wittrup IH, Rogind H, Danneskiold-Samsoe B, Bliddal H. Correlation between tender points and the Fibromyalgia Impact Questionnaire. J Musculoskel Pain 2000, 8:19-28.
29. Arnold LM, Hudson JI, Hess EV. Family study of fibromyalgia. Arthritis Rheum 2004, 50:944-952.
30. Calabrese JR, Muzina DJ, Kemp DE. Predictors of bipolar disorder risk among patients currently treated for major depression. Med Gen Med 2006, 15:38-43.
31. Kirmayer LJ, Robbins JM, Kapusta MA. Somatization and depression in fibromyalgia. Am J Psychiatry 1988, 145:950-954.
32. Epstein SA, Kay G, Clauw D. Psychiatric disorders in patients with fibromyalgia. A multicenter investigation. Psychosomatics 1999, 40:57-63.
33. Kurland JE, Coyle WJ, Winkler A, Zable E. Prevalence of irritable bowel syndrome and depression in fibromyalgia. Dig Dis Sci 2006, 51:454-460.
34. Offenbaecher M, Glatzeder K, Ackenheil M. Self-reported depression, familial history of depression and fibromyalgia (FM) and psychological distress in patients with FM. J Rheumatol 1998, 57:94-96.
35. Burckhardt CS, O'Reilly CA, Wiens AN, Clark SR, Campbell SM, Bennett RM. Assessing depression in fibromyalgia patients. Arthritis Care Res 1994, 7:35-39.
36. Turner JA, Romano JM. Self-report screening measures for depression in chronic pain patients. J Clin Psychol 1984, 40:909-913.
37. Williams AC, Richardson PH. What does the BDI measure in chronic pain? Pain 1993, 55:259-266.
38. Cohen H, Buskila D, Neumann L, Ebstein RP. Confirmation of an association between fibromyalgia and serotonin transporter promoter region (5- HTTLPR) polymorphism, and relationship to anxiety-related personality traits. Arthritis Rheum 2002, 46:845-857.
39. Cipriani A, Furukawa TA, Salanti G. Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet 2009, 373:746-758.
40. Nakagawa A, Watanabe N, Omori IM. Milnacipran versus other antidepressive agents for depression. Cochrane Database Syst Rev 2009, 3:CD006529.
41. El-Mallakh RS, Karippot A. Use of antidepressants to treat depression in bipolar disorder. Psychiatr Serv 2002, 53:580-584.
42. Aaron LA, Bradley LA, Alarcon GS. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996, 39:436-445.
43. Hirschfeld RMA, Calabrese JR, Weissman MM. Screening for bipolar disorder in the community. J Clin Psychiatry 2003, 64:53-59.
44. Khasnis A, Wilke WS. Diagnosing fibromyalgia: moving away from tender points. J Musculoskel Med 2010, 27:1-5.
45. de Dios C, Ezquiaga E. Manic switching in patients receiving duloxetine. Am J Psychiatry 2007, 164:1121.